Alambic Investment Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-16,949	Closed	-$205K	–	509
2017 Q2	$205K	Sell	16,949 -11,551	-41%	-$140K	0.02%	508
2017 Q1	$366K	Buy	28,500 +15,300	+116%	+$196K	0.05%	466
2016 Q4	$160K	Buy	+13,200	New	+$160K	0.03%	517